— Know what they know.
Not Investment Advice

MGRX NASDAQ

Mangoceuticals, Inc.
1W: -6.2% 1M: +13.8% 3M: -0.5% YTD: -48.8% 1Y: -79.3% 3Y: -96.8%
$0.44
-0.04 (-9.03%)
 
Weekly Expected Move ±16.8%
$0 $0 $0 $1 $1
NASDAQ · Healthcare · Medical - Healthcare Information Services · Tech Score Buy · Power 56 · $7.4M mcap · 13M float · 71.84% daily turnover · Short 34% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$7.4M
52W Range0.162-2.75
Volume871,159
Avg Volume9,647,412
Beta2.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJacob D. Cohen
Employees3
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2023-03-21
15110 North Dallas Parkway
Dallas, TX 75248
US
(214) 242-9619
About Mangoceuticals, Inc.

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

Recent Insider Trades

NameTypeSharesPriceDate
Cohen Jacob D. A-Award 2,000,000 $0.45 2026-03-16
Cohen Jacob D. A-Award 83,333 $0.45 2026-03-16
Cohen Jacob D. A-Award 50,000 $0.45 2026-03-16
Cohen Jacob D. D-Return 2,000,000 $2.30 2026-03-16
Cohen Jacob D. D-Return 83,333 $4.80 2026-03-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms